Zacks.com on MSN8h
Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates
Akoya Biosciences (AKYA) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year ago. These figures ...
Akoya: Q3 Earnings Snapshot
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Thursday reported a loss of $10.5 million in its third quarter. On a per-share basis, the Marlborough, ...
Craig-Hallum Sticks to Its Buy Rating for Akoya Biosciences (AKYA)
In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Akoya Biosciences (AKYA – Research Report). The ...
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Decrease in Short Interest
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totalling 2,020,000 shares, a drop ...
Morningstar10d
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
Nov. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, will unveil innovations designed to accelerate insights in immuno-oncology ...
Akoya BiosciencesQ3每股收益及营收逊于预期
英为财情Investing.com - Akoya Biosciences (NASDAQ: AKYA )星期四发布了第三季度的财报，数据显示，公司营收逊于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.210，总营收为$18.8M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$25.43M，每股收益为$-0.200 ...
Investing3d
Akoya Biosciences Inc (AKYA)
Investing.com - Akoya Biosciences (NASDAQ: AKYA) reported second quarter EPS of $-0.51, $0.07 worse than the analyst estimate of $-0.44. Revenue for the quarter came in at ...
Mersana Therapeutics Reports Q3 2024 Financial Results
Mersana Therapeutics ( (MRSN) ) has released its Q3 earnings. Here is a breakdown of the information Mersana Therapeutics presented to its ...